Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level

Autor:	Ronald H. W. M. Derksen, Jwj Bijlsma, J.A. van Roon, M. Canniǹga-van Dijk, A. W. A. M. van Rijthoven
Rok vydání:	2006
Předmět:	biology business.industry Anti-dsDNA antibodies medicine.disease Infliximab Rheumatology Blisibimod Rheumatoid arthritis Immunology biology.protein Adalimumab Medicine Pharmacology (medical) business Anti-SSA/Ro autoantibodies medicine.drug
Zdroj:	Rheumatology. 45:1317-1319
ISSN:	1462-0332 1462-0324
DOI:	10.1093/rheumatology/kel227
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::5708853bdc3f04078407332f6ec9012c https://doi.org/10.1093/rheumatology/kel227 Zobrazit plný text záznamu